These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4568279)

  • 1. Clinical experience with the Cu-7 intrauterine device.
    Bernstein GS; Israel R; Seward P; Mishell DR
    Contraception; 1972 Aug; 6(2):99-107. PubMed ID: 4568279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with the copper 7 intrauterine device in an adolescent population.
    Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
    J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A statistical study of the copper T and copper 7 intrauterine devices.
    Gupta HD; Gupta I; Devi PK
    Contraception; 1976 Dec; 14(6):655-60. PubMed ID: 1017199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year clinical experience with FlexiGard.
    Batar I
    Contraception; 1992 Oct; 46(4):307-12. PubMed ID: 1486769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year study of the copper T 200 intrauterine device.
    Gupta HD; Devi PK
    Contraception; 1976 Aug; 14(2):165-9. PubMed ID: 949893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies on Cu-7; copper-IUD.
    Matsumoto S
    Nihon Funin Gakkai Zasshi; 1976 Jul; 21(3):70-82. PubMed ID: 12158549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate postpartum insertion of a copper-wired intrauterine contraceptive device, the MLCu250.
    Thiery M; Van Der Pas H; Delbeke L; Van Kets H
    Br J Obstet Gynaecol; 1979 Aug; 86(8):654-8. PubMed ID: 497136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with three different models of the Copper T intrauterine contraceptive device in nulliparous women.
    Roy S; Cooper D; Mishell DR
    Am J Obstet Gynecol; 1974 Jun; 119(3):414-7. PubMed ID: 4827383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical study of the TCu-380 A and the TCu-200 B. IUDs.
    Kandil OF; El-sheikha Z; Hamza A
    Popul Sci; 1991 Jan; 10():35-40. PubMed ID: 12284660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised trial and a comparative study of the copper 7 200 and the multiload copper 250 intrauterine devices.
    Wilson J
    Aust N Z J Obstet Gynaecol; 1982 Feb; 22(1):34-7. PubMed ID: 7049154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women.
    Mishell DR; Israel R; Freid N
    Am J Obstet Gynecol; 1973 Aug; 116(8):1092-6. PubMed ID: 4721138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do insertion-related problems affect subsequent IUD performance?
    Chi IC; Waszak CS; Wilkens LR
    Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.